search
NASDAQ:GALT
USD
1.35
- (-3.6%)
GALECTIN THERAPEUTICS INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
USD 1.350
- (-3.6%)
End of Day: 9 May 2025 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other d...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices